1 / 13

Depression Drugs Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Global Depression Drug Market is estimated to reach $18 billion by 2024; growing at a CAGR of 2.6% from 2016 to 2024. Depression has emerged as one of the most common yet serious mental disorders among people globally. Depression is caused by combination of genetics, biological, environment and psychological factors.

priyasharma14
Télécharger la présentation

Depression Drugs Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Depression Drugs Market is Expected to Reach $18 Billion, by 2024, Says Variant Market Research Yogesh Godse Director help@variantmarketresearch.com Variant Market Research

  2. Description - Depression Drugs Market • Global Depression Drug Market is estimated to reach $18 billion by 2024; growing at a CAGR of 2.6% from 2016 to 2024. Depression has emerged as one of the most common yet serious mental disorders among people globally. Depression is caused by combination of genetics, biological, environment and psychological factors. According to WHO published in 2016, estimated 350 million people have been affected and depression can lead to suicide. Over 800000 people die due to suicide every year, making it the second leading cause of death in 15-29 year olds. Depression is more common in women than men. Depression drugs works by fixing chemical imbalance, especially, lack of serotonin in the brain. Although effective treatments are available, many individuals with depression do not have access to treatment or do not take treatment, mainly due to lack of knowledge and social stigma. • To Know More About This Report, Visit Here: http://bit.ly/2pZLVUZ Source : Variant Market Research

  3. Global Depression Drugs Market Size and Forecast 2015-2024 Source : Variant Market Research

  4. Depression Drugs Market • Growing geriatric population, increase in the knowledge regarding depression and rising number of generic drug market are expected to drive the market. Moreover, support from government organizations could also support the growth of market. However, lack of resources, lack of trained healthcare providers and social stigma could be a barrier for the growth of market. Research and development and Untapped markets could provide an opportunity for the market in upcoming years. Source : Variant Market Research

  5. Global Depression Drugs Market Share by Region 2024 Source : Variant Market Research

  6. Scope of Depression Drugs Market • Product Type Segments • Tricyclice Antidepressants • Serotonin-Norepinephrine Inhibitors • Atypical Antipsychotics • Selective Serotonin Reuptake Inhibitors • Benzodiazepines, Tetracyclic Antidepressants • Monoamine Oxidase Inhibitors • Others • Application Segments • Clinics and Hospitals • Research centres Source : Variant Market Research

  7. Scope of Depression Drugs Market • Geographical Segments • North America • US • Canada • Mexico • Europe • Germany • France • United Kingdom • Spain • Others Source : Variant Market Research

  8. Scope of Depression Drugs Market • Geographical Segments • Asia-Pacific • China • India • Japan • South Korea • Others • RoW • South America • Middle East • Africa Source : Variant Market Research

  9. Table Of Content • Chapter 1. Prefix     1.1. Market Scope     1.2. Report Description     1.3. Research Methodology           1.3.1 Primary Research           1.3.2 Secondary Research           1.3.3 In-house Data ModelingChapter 2. Executive Summary

  10. Table Of Content • Chapter 3. Market Outline     3.1 Market Inclination, Trend, Outlook and Viewpoint     3.2 Market Share Analysis: Company’s Competitive Scenario     3.3 Value Chain Analysis     3.4 Market Dynamics            3.4.1 Drivers                 3.4.1.1 Impact Analysis           3.4.2. Restraints                 3.4.2.1 Impact Analysis           3.4.3 Opportunities     3.5 Porter’s five forces analysis           3.5.1 Factors Impact Analysis • ….... Source : Variant Market Research

  11. Table Of Content • Chapter 7. Company Profiles     7.1 H.Lundbeck, Merck & Co.     7.2 SK Biopharmaceuticals     7.3 Novartis     7.4 AstraZeneca     7.5 Forest Laboratories     7.6 Naurex     7.7 GlaxoSmithKline     7.8 Eli Lilly and Co. Source : Variant Market Research

  12. Contact Us VARIANT MARKET RESEARCH LLPWeb: https://www.variantmarketresearch.com USA Office:649 Mission St., 5th Floor, San Francisco, CA 94105, United States.Tel: +1-415-680-2785Fax: +1-415-680-2786Email: help@variantmarketresearch.com Orsales@ variantmarketresearch.com India Office (Corporate Headquarter):Office No. FL No.7, Prakash Developers, Survey no 34/A5, Wadgaon Sheri, Nagar Road, Pune – 411014Tel: +91 20 65337795 Source : Variant Market Research

  13. Thank You… • Follow us @vmrreports variantmarketresearch Variant Market Research variant-market-research Source : Variant Market Research

More Related